Epigenetic Activation of SOX11 is Associated with Recurrence and Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer

Medicine, Oncology, Life Sciences, Cell Biology, Biochemistry, Immunology,
SOX11   Ductal Carcinoma In Situ   Invasive Breast Cancer   Recurrence   Epigenetics   Biomarker   Progression  

Epigenetic Activation of Sox11 in Recurrence and Progression of Ductal Carcinoma In Situ Background Ductal Carcinoma In Situ (DCIS) is a non-invasive breast cancer characterized by the excessive proliferation of luminal epithelial cells surrounded by myoepithelial cells. DCIS accounts for approximately 25% of breast cancer screenings, and its poten...

Resistance, Rebound, and Recurrence Regrowth Patterns in Pediatric Low-Grade Glioma Treated by MAPK Inhibition: A Modified Delphi Approach to Build International Consensus

Medicine, Pediatrics, Neurology, Neurosurgery, Oncology,
Pediatric   Low-Grade Glioma   MAPK Inhibition   Resistance   Recurrence   Rebound   Delphi Method  

International Consensus on Resistance, Rebound, and Recurrence in Pediatric Low-Grade Glioma with MAPK Inhibition Therapy: Established Using a Modified Delphi Method Academic Background Pediatric low-grade glioma (PLGG) is the most common type of tumor in the central nervous system of children. Although these tumors have a relatively high overall s...